3-(4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)bicyclo[2.2.2]octan-1-yl)propanoic acid

ID: ALA414157

Max Phase: Phase

Molecular Formula: C22H32N4O4

Molecular Weight: 416.52

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Synonyms: Tonapofylline | BG-9928 | BG9928

Canonical SMILES:  CCCn1c(=O)c2[nH]c(C34CCC(CCC(=O)O)(CC3)CC4)nc2n(CCC)c1=O

Standard InChI:  InChI=1S/C22H32N4O4/c1-3-13-25-17-16(18(29)26(14-4-2)20(25)30)23-19(24-17)22-10-7-21(8-11-22,9-12-22)6-5-15(27)28/h3-14H2,1-2H3,(H,23,24)(H,27,28)

Standard InChI Key:  ZWTVVWUOTJRXKM-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
   -3.1583    0.2833    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1583   -0.5417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4463   -0.9500    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4463    0.7000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7343    0.2833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7343   -0.5427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9487   -0.7980    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4631   -0.1297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9487    0.5385    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3619   -0.1297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7717   -0.8514    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5931   -0.8534    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5982    0.5756    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7706    0.5792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8345   -0.1438    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2497    0.5691    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0747    0.5659    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4899    1.2788    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.4845   -0.1501    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4463    1.5250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4468   -1.7750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7325   -2.1879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0178   -1.7758    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8722   -0.9552    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8740    0.6937    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5873    0.2791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3029    0.6896    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0708    0.2875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2833   -0.5083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9958   -0.0917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 30 13  1  0
 13 14  1  0
  2  3  1  0
 30 15  1  0
  3  6  1  0
 15 16  1  0
  6  7  1  0
 16 17  1  0
  7  8  2  0
 17 18  2  0
  8  9  1  0
 17 19  1  0
  9  5  1  0
  4 20  2  0
  5  4  1  0
  3 21  1  0
  8 10  1  0
 21 22  1  0
 10 11  1  0
 22 23  1  0
  5  6  2  0
  2 24  2  0
  1 25  1  0
  1  2  1  0
 25 26  1  0
  1  4  1  0
 26 27  1  0
 10 14  1  0
 10 28  1  0
 11 12  1  0
 28 29  1  0
 12 30  1  0
 29 30  1  0
M  END

Associated Targets(Human)

ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA2A Tclin Adenosine A2a receptor (16305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA2B Tclin Adenosine A2b receptor (7672 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA3 Tchem Adenosine A3 receptor (15931 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA1 Tclin Adenosine receptors; A1 & A2a (250 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA1 Tclin Adenosine receptors; A1 & A2b (259 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Adora1 Adenosine A1 receptor (6163 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adora2a Adenosine A2a receptor (3360 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: YesAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 416.52Molecular Weight (Monoisotopic): 416.2424AlogP: 3.16#Rotatable Bonds: 8
Polar Surface Area: 109.98Molecular Species: ACIDHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 4.13CX Basic pKa: CX LogP: 3.47CX LogD: 0.29
Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.69Np Likeness Score: -0.11

References

1. Vu CB, Kiesman WF, Conlon PR, Lin KC, Tam M, Petter RC, Smits G, Lutterodt F, Jin X, Chen L, Zhang J..  (2006)  Tricyclic imidazoline derivatives as potent and selective adenosine A1 receptor antagonists.,  49  (24): [PMID:17125265] [10.1021/jm060539t]
2. Scheiff AB, Yerande SG, El-Tayeb A, Li W, Inamdar GS, Vasu KK, Sudarsanam V, Müller CE..  (2010)  2-Amino-5-benzoyl-4-phenylthiazoles: Development of potent and selective adenosine A1 receptor antagonists.,  18  (6): [PMID:20188574] [10.1016/j.bmc.2010.01.072]
3. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, 
4. Unpublished dataset,